Drugs / PP1131
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02116010 | Jul 2015 → Jul 2016 | skin infection | Phagenix | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PP1131 | “Eligible participants were randomly assigned (1:1) by use of an interactive web response system to a cocktail of 12 natural lytic anti-P aeruginosa bacteriophages (PP1131;...” PMID 30292481 ↗ Oct 2018 |
| Modality | Other / unclassified | “a cocktail of 12 natural lytic anti-P aeruginosa bacteriophages” PMID 30292481 ↗ Oct 2018 |
| Route | Topical | “both given as a daily topical treatment for 7 days” PMID 30292481 ↗ Oct 2018 |